首页> 外文OA文献 >A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

【2h】

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

机译：利用HE4和CA125的新型多种标记生物测定，用于预测盆腔质患者卵巢癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Richard G. Moore; D. Scott McMeekin; Amy K. Brown; Paul DiSilvestro; M. Craig Miller; W. Jeffrey Allard; Walter Gajewski; Robert Kurman; Robert C. Bast; Steven J. Skates;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. [J] . Moore RG, McMeekin DS, Brown AK, Gynecologic Oncology: An International Journal . 2009,第1期

机译：利用HE4和CA125预测骨盆肿患者卵巢癌的新型多标记生物测定法。
2. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study [J] . Romagnolo Cesare, Leon Antonette E., Fabricio Aline S. C., Gynecologic Oncology: An International Journal . 2016,第2期

机译：HE4，CA125和卵巢恶性算法（ROMA）风险作为盆腔肿块患者卵巢癌的诊断工具：一项意大利多中心研究
3. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass [J] . KarlsenM.A., SandhuN., H?gdallC., Gynecologic Oncology: An International Journal . 2012,第2期

机译：评估HE4，CA125，卵巢恶性算法（ROMA）的风险和恶性指数（RMI）的风险作为盆腔肿块患者上皮性卵巢癌的诊断工具
4. Biomarker CA125 Feature Engineering and Class Imbalance Learning Improves Ovarian Cancer Prediction [C] . Xiaoyan Yang, Matloob Khushi, Kamran Shaukat IEEE Asia-Pacific Conference on Computer Science and Data Engineering . 2020

机译：Biomarker CA125特征工程和级别不平衡学习改善了卵巢癌预测
5. Role of ovarian cancer antigen CA125/MUC16 in development and cancer. [D] . Cheon, Dong-Joo (Ellen). 2009

机译：卵巢癌抗原CA125 / MUC16在发育和癌症中的作用。
6. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass [O] . Richard G. Moore, D. Scott McMeekin, Amy K. Brown, -1

机译：利用HE4和CA125预测骨盆肿患者卵巢癌的新型多标记生物测定法
7. Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 [O] . Michèl Schummer, Charles Drescher, Robin Forrest, 2012

机译：通过与已建立的标记CA125进行比较评价卵巢癌缓解标记物HE4，MMP7和MESOTHELIN
8. Tumor Marker CA 125: The Clinical Significance of the Serum Marker CA 125 in the Management of Patients with Ovarian Cancer [R] . van der Burg, M. E. L. 1989

机译：肿瘤标志物Ca 125：血清标志物Ca 125在卵巢癌患者管理中的临床意义

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

著录项

引文网络

相似文献

相关主题

期刊订阅